Entering text into the input field will update the search result below

Evoke Pharma pops 8% after Gimoti listed in FDA Orange Book

  • Evoke Pharma (NASDAQ:EVOK) jumps 8.4% premarket in reaction to the announcement that its US patent No. 11,020,361 for Gimoti (metoclopramide) nasal spray is now listed in the FDA's “Orange Book”.
  • The patent covers methods of use for nasal delivery of metoclopramide for the

Recommended For You

About EVOK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EVOK--
Evoke Pharma, Inc.